UNIVERSAL HEALTH REALTY INCOME TRUST — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNIVERSAL HEALTH REALTY INCOME TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.19M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $99.01M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $95.58M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $90.63M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $84.19M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $19.83M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $19.69M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $19.28M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $19.21M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $18.86M | Feb 25, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2018 | $9.20M | Feb 26, 2020 |
| FY2019 | Dec 31, 2017 | $8.30M | Feb 26, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.61M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $19.23M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $15.40M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $21.10M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $109.17M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $5.00M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $5.19M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $4.70M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $4.55M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $5.84M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.76M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $36.80M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $31.35M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $30.67M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $28.87M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $26.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $25.75M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $26.71M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $24.04M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $22.11M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.09M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $46.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $42.94M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $46.81M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $47.73M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $44.21M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $42.65M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $42.93M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $46.01M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $40.73M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2023 | $7.62M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $13.62M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $12.99M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.27M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $5.11M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $4.05M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $9.04M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $60.39M | Feb 27, 2019 |
| FY2017 | Dec 31, 2015 | $16.77M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $15.60M | Feb 28, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $564.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $580.86M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $596.37M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $607.54M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $598.42M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $494.01M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $488.79M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $483.76M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $490.01M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $524.75M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $412.52M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $401.32M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $395.44M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $378.44M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $363.09M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $335.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $307.06M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $285.15M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $279.45M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $333.47M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.38M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $179.54M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $200.93M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $229.10M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $235.33M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $159.01M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $181.73M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $198.61M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $210.56M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $191.28M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $862.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $845.30M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $826.06M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $810.66M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $789.56M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $680.73M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $661.28M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $642.32M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $618.12M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $572.50M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.69M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $7.10M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $8.21M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $7.61M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $22.50M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $5.74M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $6.11M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $5.04M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $3.39M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $3.93M | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $374.77M | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | $368.41M | Feb 26, 2025 |
| FY2023 | Dec 31, 2023 | $359.66M | Feb 27, 2024 |
| FY2022 | Dec 31, 2022 | $343.05M | Feb 27, 2023 |
| FY2021 | Dec 31, 2021 | $329.05M | Feb 24, 2022 |
| FY2020 | Dec 31, 2020 | $295.43M | Feb 25, 2021 |
| FY2019 | Dec 31, 2019 | $274.09M | Feb 26, 2020 |
| FY2018 | Dec 31, 2018 | $261.75M | Feb 27, 2019 |
| FY2017 | Dec 31, 2017 | $256.79M | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | $315.66M | Feb 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.87M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 13.85M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 13.82M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 13.80M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 13.79M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | 13.77M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 13.76M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 13.75M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | 13.74M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 13.60M | Feb 28, 2018 |